MacroGenics
MGNX
113 hedge funds and large institutions have $583M invested in MacroGenics in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 48 increasing their positions, 29 reducing their positions, and 11 closing their positions.
66% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 29
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
37% more call options, than puts
Call options by funds: $824K | Put options by funds: $600K
6% more capital invested
Capital invested by funds: $549M → $583M (+$34.6M)
9% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 11
0% more funds holding
Funds holding: 113 → 113 (0)
3.66% less ownership
Funds ownership: 89.48% → 85.82% (-3.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Pinnacle Associates
New York
|
+$4.05M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
+$2.45M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.24M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$2.21M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$2.02M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$14.5M |
| 2 |
EOJOAM
E. Ohman J:or Asset Management
Stockholm,
Sweden
|
-$3.45M |
| 3 |
AG
Artal Group
Luxembourg
|
-$1.73M |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$1.47M |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$1.29M |
MGNX Hedge Fund Activity: Q3 2017 in Review
113 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q3 2017, worth a combined $583M — up 6.3% from $549M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new MGNX positions and 11 closed out — a net gain of 1 holder — while 48 added to existing stakes and 29 trimmed.
The largest buyer was Pinnacle Associates, adding an estimated $4.05M. The largest seller was Fidelity Investments, cutting an estimated $14.5M.
- 113 institutional investors held MacroGenics (MGNX) as of Q3 2017, unchanged from Q2 2017.
- Funds reported $583M of MacroGenics stock for Q3 2017, up 6.3% quarter-over-quarter.
- 12 funds opened new MacroGenics positions in Q3 2017 and 11 closed out, a net change of +1 holder.
- The largest MacroGenics buyer in Q3 2017 was Pinnacle Associates, an estimated $4.05M added.
- The largest MacroGenics seller in Q3 2017 was Fidelity Investments, an estimated $14.5M sold.
Based on aggregated 13F filings for Q3 2017.